Reuters logo
BRIEF-Quantum Genomics recruits first patients in NEW-HOPE hypertension study in the US
November 15, 2017 / 6:40 AM / in 10 days

BRIEF-Quantum Genomics recruits first patients in NEW-HOPE hypertension study in the US

Nov 15 (Reuters) - QUANTUM GENOMICS SA:

* ‍QUANTUM GENOMICS ANNOUNCES RECRUITMENT OF FIRST PATIENTS IN NEW-HOPE ARTERIAL HYPERTENSION STUDY IN UNITED STATES​

* ‍PATIENTS IN UNITED STATES TO PARTICIPATE IN NEW-HOPE STUDY, DESIGNED TO EVALUATE EFFICACY OF DRUG CANDIDATE QGC001 IN TREATMENT OF HIGH BLOOD PRESSURE​

* ‍STUDY RESULTS ARE EXPECTED IN FIRST HALF OF 2019​

* ‍PRIMARY EFFICACY ENDPOINT IS A LOWER BLOOD PRESSURE READING AFTER EIGHT-WEEK PERIOD​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below